首页> 外文期刊>Pharmaceutical research >Isothermal Microcalorimetry of pressurized systems I: A rapid method to evaluate pressurized metered dose inhaler formulations
【24h】

Isothermal Microcalorimetry of pressurized systems I: A rapid method to evaluate pressurized metered dose inhaler formulations

机译:加压系统的等温微量热法I:一种评估加压计量吸入器配方的快速方法

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose: The techniques available to study formulation stability in pressurized metered dose inhalers (pMDIs) are limited, due to the challenging conditions of working with high pressure propellants. Isothermal microcalorimetry is a valuable tool used to screen and aid in formulation development of solid and solution drug formulations; however there are currently no available methods to evaluate pMDIs. In this paper, we have developed a method that allows measurement of such pressurized systems.Methods: Samples were prepared by cold filling ampoules with propellant (HFA 134a) and drugs of interest. Ampoule caps were fitted with a specific O-ring, coated with paraffin and pre-conditioned prior to measurement. Samples were equilibrated at 25°C, placed in a Thermal Activity Monitor III (TAM III) system and measured isothermally at 25°C for a period of at least 24 h.Results: Using well-defined procedures and ampoule preparation techniques we were able to safely contain the volatile propellant and acquire a stable measurement baseline. We were able to rapidly determine, within 6 h, the physical stability of amorphous and crystalline drug forms of beclomethasone dipropionate and formoterol fumarate dihydrate when formulated with HFA 134a.Conclusions: Isothermal microcalorimetry in pressurized HFA propellant systems was shown to be a rapid screening tool to evaluate pMDI formulation physical stability. This method can potentially be applied to study pMDI formulation factors to expedite product development.
机译:目的:由于使用高压推进剂的挑战性条件,可用于研究加压定量吸入器(pMDI)中制剂稳定性的技术有限。等温微量热法是一种有价值的工具,可用于筛选和协助固体和溶液药物制剂的制剂开发;但是,目前没有评估pMDI的可用方法。在本文中,我们开发了一种可测量此类加压系统的方法。方法:通过将安瓿药与推进剂(HFA 134a)和目标药物冷填充来制备样品。安瓿瓶盖上装有特定的O形圈,涂有石蜡并在测量前进行了预处理。将样品在25°C下平衡,放置在热活动监测器III(TAM III)系统中,并在25°C下等温测量至少24小时。结果:使用定义明确的程序和安瓿瓶制备技术,我们能够以安全地包含挥发性推进剂并获得稳定的测量基线。用HFA 134a配制后,我们能够在6小时内快速确定无定形和结晶药物形式的倍氯米松二丙酸酯和富马酸福莫特罗二水合物的物理稳定性。结论:加压HFA推进剂系统中的等温微量热法是一种快速筛选工具评估pMDI制剂的物理稳定性。该方法可潜在地用于研究pMDI配方因素以加快产品开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号